rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1990-8-30
|
pubmed:abstractText |
Whether patients in clinical remission for acute lymphoblastic leukemia (ALL) continue to harbor leukemic cells is not known, because methods of detecting residual malignant cells have not been sufficiently sensitive. This information might be useful for predicting recurrence and determining the duration of therapy.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
323
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
448-55
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:2095753-Adolescent,
pubmed-meshheading:2095753-Base Sequence,
pubmed-meshheading:2095753-Bone Marrow,
pubmed-meshheading:2095753-Burkitt Lymphoma,
pubmed-meshheading:2095753-Child,
pubmed-meshheading:2095753-Child, Preschool,
pubmed-meshheading:2095753-DNA, Neoplasm,
pubmed-meshheading:2095753-Female,
pubmed-meshheading:2095753-Humans,
pubmed-meshheading:2095753-Infant,
pubmed-meshheading:2095753-Male,
pubmed-meshheading:2095753-Molecular Sequence Data,
pubmed-meshheading:2095753-Polymerase Chain Reaction,
pubmed-meshheading:2095753-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
|
pubmed:affiliation |
Wistar Institute, Philadelphia, PA 19104.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|